Van Vollenhoven R, Hahn BH, Tsokos GC, et al. Efficacy and Safety of Ustekinumab, an Interleukin 12/23 Inhibitor, in Patients with Active Systemic Lupus Erythematosus: Results of a Phase 2, Randomized Placebo-Controlled Study. ACR 2017, abstract 6L.
Associatie miR200b-5p-expressie en non-hodgkinlymfoom bij Sjögren
okt 2018 | Sjögren